Mesoblast shares surge again as stem cell treatment helps bone marrow transplants – Business Insider Australia
Business Insider Australia |
Mesoblast shares surge again as stem cell treatment helps bone marrow transplants
Business Insider Australia Shares in biotech company Mesoblast are soaring again, this time because its stem cell treatment has been found effective in helping children survive bone marrow transplants. A short time ago, the shares were 16% higher at $1.755. Last week a trial of … |
